by Rick Dana Barlow
As
one of the five largest, and technically one of the oldest, group
purchasing organizations in healthcare, St. Louis-based Amerinet Inc. (www.amerinet-gpo.com)
has enjoyed its steady climb to its current position of market
prominence since its inception in 1986. In fact, the GPO reported
delivering $310 million in contract portfolio savings and distributing
$30 million in shareback funds to members in fiscal 2004, which ended
September 30. Amerinet’s board also reported that member purchases
topped $6 billion for the first time in fiscal 2004.
Amerinet launched several new initiatives last year, as
well as acquired the oldest regional GPO in the nation and expanded its
executive offices. Healthcare Purchasing News Senior Editor Rick
Dana Barlow spoke with Amerinet President and CEO Robert P. "Bud" Bowen
about the GPO’s activities in 2004 and its strategic direction ahead.
HPN:
As president
of Amerinet you’ve now assumed the office of CEO to oversee the GPO’s
strategic direction. What are some of your initial plans right out of
the gate? Why couldn’t you initiate these goals without the CEO title?
BOWEN:
The changes that we’ve made here are really a lot less about me than it
is about Todd Ebert stepping up and assuming more day-to-day
responsibilities as president of operations for Amerinet and also with
Wayne Thompson joining the organization as president of health systems
integration. Those changes are allowing me to sit on the Amerinet board,
obviously still as a senior member of executive management. But frankly,
it allows me to get away from the day-to-day operations and management
of the company and to spend more time in some of the strategic things
that we need to be doing as an organization. Specifically, it’s my
intention to try to get out and spend more time with the senior
executives at our key members and understand what their needs are and
making sure that we’re being responsive to their needs and potentially
meeting with prospective members as well. That’s an important thing that
I’ll now have time to do that I really didn’t before.
I also plan to put more time into some of the general
industry initiatives that we’ve been involved in and have been very
supportive of. We’re a member of NAHIT, the Coalition to Protect
America’s Healthcare, which is going to be faced with a lot of
challenges next year and certainly the group purchasing issues in D.C.
are also something I’m very much involved in. Those are the key things
that I’ll be spending more time on, especially now that Todd and Wayne
will be taking on more day-to-day responsibility.
Which areas do you see as becoming
more crucial to the future than it is now for Amerinet?
We recognize – and I think most GPOs recognize – that we
all have to find ways to bring more value to our members. The members
are obviously under severe economic strain, and the traditional GPO
model needs to be expanded to make sure that we’re providing whatever
areas we can for cost reduction and assistance to the members. That’s
really beyond the traditional group purchasing. That’s probably the most
important thing that we have to do.
By traditional group purchasing I’m talking about
negotiating contracts, providing contracts with discounted terms and
pricing. That’s obviously still a very critical and essential function
of what we have to do. But we have to actually reach out and go beyond
that. Our members are asking us to do a lot more than that. Data
management support in our new company, Diagnostix, is a perfect example
of that. It’s become clear to us that hospitals really struggle with the
amount of data that they have to deal with. Keeping it all straight is
just an overwhelming burden and they look to the GPO to help ease that
burden and make it better for them.
We’re also moving into two other areas. We’ve had a
program called Options for quite some time. We were really the first GPO
to step out of the box and recognize that there are some product areas
that our large IDN customers have the ability to drive pricing on their
own. GPOs – at least Amerinet – shouldn’t be in the position of saying
that we don’t want you to do your own contract; we want you to use our
contract. The bottom line is that we’re there to serve the needs of the
member. Rather than creating that line in the sand, our approach was to
help them. We recognize that we’ve got to do more of that. We’ve got to
make sure that we have the resources and the structure in place to be
able to support more of that customized contracting for our large IDN
customers.
We’ve dedicated resources to do this in our organization
since the late 1990s. I like to think that Options actually is a pretty
mature program of ours. It’s just a matter of keeping the resources in
the pipeline to keep up with the demand. I think we’ve got the systems
and mechanisms to do it. When we first introduced it, as you can
imagine, there was a lot of concern raised from the supplier community
questioning our customizing contracts we already had in place for a
particular customer. It’s not an easy thing to maneuver through, but you
have to stick to the fundamental concept that says, first of all, we
don’t just go and do it just because the member wants a better price.
Everybody wants a better price. But there are legitimate situations when
the member can bring incremental value to the supplier – whether it’s
through additional commitment or standardization or length of contract
or any variety of things – then it is also reasonable for that member to
expect better consideration in the arrangement. That’s what we
facilitate.
The second one, of course, was confidentiality. I really
do believe that we’ve earned the respect of the supplier community. When
we do these Options programs, which are basically one-off modification
contracts for a particular member it’s important that we simply not take
that deal and go to the next member and then club the vendor over the
head with it. We’ve not done that, and that was their concern. So I
think they’ve come to respect the process that we have and the integrity
of it. It’s a very successful program. It’s a win for everybody.
How many members are supporting the
Options program?
I think we’re probably dealing with 30 or 40 of our
members, involving about 150 contracts altogether. Of course, you don’t
do these things for cotton balls. You do these for the big ticket items
that have a big impact on the members.
Such as physician preference items?
That’s actually related to it but it’s even over and
above that. That’s really the next area of the initiative that we’re
very much into. This is a program that we’re expanding because it’s
become so successful and so popular. That’s our Clinical Advantage
program. It’s much the same in that it is a customized contracting
effort for a particular system but it is specifically aimed at the
traditionally difficult product areas for GPOs to tackle, which are the
big ticket clinical preference product areas, particularly orthopedics
and cardiology. Obviously, that requires clinical resources on staff at
Amerinet, which we have, and a lot of data management in that particular
activity. It’s a significant investment of ours. But the results of this
program have just been staggering.
What do you see as being less
crucial?
The answer to that is nothing. It would be nice to say
that we’re going to do more of this but at the same time a little less
of this. There isn’t anything that I could come up with that we have the
liberty of doing less of. Everything that we have ever done historically
is just as important as it always has been. We certainly need to
continue doing it and we will. We’ve got to continue to provide a broad
and deep portfolio of agreements to serve our membership. And all of the
new things are going to be over and above, layered on top of what we
already do.
What do you see as the single
biggest growth area for Amerinet over the next five years and why?
In the next five years you’re going to see our dramatic
growth probably coming from growing our IDN business. The main reason is
because our business model is the one that’s best suited particularly
for the large IDNs. Our philosophy of choice and flexibility and
customized contracting has been our hallmark since Day One. That really
resonates well with IDNs. They like the concept that Amerinet works with
them to develop customized solutions for their needs rather than
mandated compliance and mandated participation. We’re getting a lot of
receptivity. We actually see ourselves almost by default facilitating a
virtual alliance of IDN members around the country. It’s anchored by one
of our owner companies, Intermountain Health Care. We facilitate a
number of meetings, and they’ve been extremely popular and valuable,
that bring together IDNs from around the country that are not
competitive with one another. They create an opportunity to network
amongst each other for successful strategies and tactics to improve
their performance. It’s sort of taking on a life of its own. There’s a
lot of demand for it. We’re facilitating it more and we’re looking into
other areas where it can go.
When do these meetings take place?
I think the next one is in the spring. We hold these
meetings once or twice a year. We respond to them as we can. It’s
difficult for the members to get out. But they’re at least once or twice
a year.
Amerinet has staked a solid claim
in the specialty surgical hospital market segment as well as in the
physician practice segment courtesy of strategic alliances with ASHA and
MGMA. What were the motivations behind these decisions and how do you
move forward given the brewing controversy among physician-owned
surgical hospitals that is threatening to spill over into
physician-owned surgery centers?
Amerinet was the first large national acute care-based
GPO to step out into the nonacute care markets and that decision was
made early on in our inception in the late 1980s. In fact, our
relationship with MGMA goes back to 1988. It was a difficult decision
because if you take a look at the spend in hospitals it’s obviously
significantly greater on a site-by-site basis than it is in nonacute
care facilities. Whether it was sheer brilliance or just coincidence, in
any event, by being in the nonacute care markets – particularly the
long-term care facilities, the surgery centers when they were just
emerging as part of the continuum of healthcare, home health and large
and rural clinics we developed an understanding of those different
marketplaces and the fact that as providers they had different needs
than acute care hospitals. Sometimes they required different products in
the portfolio and different distribution channels. By understanding that
early on we’ve developed a real strong position in the nonacute care
markets. Only in the last few years have a lot of the other national
GPOs decided that these are markets that they need to be in. You don’t
just jump in and out of it. It’s a very unique industry and what was
really exciting was in the 1990s when acute care hospitals began to come
together in a frantic pace to form IDNs one of the first demands they
had was "what was my GPO going to do to help me support four hospitals,
three surgery centers, 10 physician offices, a home health network and
two skilled nursing facilities?" We were right there.
Now the surgical hospital issue is a little bit
different. That’s a very good market for us. We support that market well
and we have some great relationships. But the issues surrounding that
particular market are really more political and social than medical in
nature. As long as they’re healthcare providers we’re going to be there
to work with them. Whatever issues they have to work out are going to
have to be sorted out in the political and social environment. But as
long as they’re delivering care we’ll be there to support them with
group purchasing.
Absorbing JPC, one of the oldest
GPOs in the nation, was quite a symbolic win for Amerinet, was it not?
How do you think the founders of JPC, including the late Bill Doll,
would react to the move?
We don’t look at it as a "win" in a competitive sense,
but I’ve known that organization for a long time. In fact, Bill Doll was
a friend and an associate of mine. As the discussions unfolded,
culturally, philosophically and ethically the two organizations were
very aligned, very compatible. We felt the merger of the two
organizations yielded a lot of benefits for the members of both. That’s
really what the win is. It’s not so much a competitive win, although
it’s nice to get into a relationship like that, but it’s really a win
for the members. It did a number of things for us. We’re particularly
intrigued by their LLC business model, which is very consistent and
compatible with what we’ve been doing with the IDNs in the customized
contracting area. I think it’s the next level of sophistication for what
we’re already doing. On the other hand, we bring to the JPC members a
tremendous breadth and depth of contract portfolio that they were
probably not going to be able to develop on their own.
Bill was a long time friend and associate. One thing
about Bill: He was always committed to doing the right thing for his
members. And I think that Bill would applaud the decision that was made
by the JPC board.
Whatever happened to that capital
equipment initiative that involved members trying out new technologies
for vendors?
What we thought we would do was facilitate members being
able to evaluate emerging technologies. We had a pilot on that and
floated that concept out, particularly to the small innovative
manufacturers. We figured, what better way for them to develop their
product to be successful than to get early input from users? We created
a structure that would have allowed the vendor community to do that,
particularly these small companies, and frankly, it died on the vine
from a lack of interest on the supplier side. We had a number of members
tell us that it was an exciting idea and they would love to participate
in it but we could never get any traction from the suppliers so we
walked away from it after the trial period.
What’s the motivation and strategic
decision behind launching Diagnostix in 2004? What does Amerinet hope to
accomplish?
It’s all tied to needing to reach beyond traditional
group purchasing. I think it’s generally agreed that current GPO
contract market is somewhere in the $65 billion to $70 billion dollar
range across all the GPOs. But the product spend for hospitals and
healthcare organizations outside of those contracts could be twice as
much as that – $150 billion. So that’s a lot of spend on the part of the
members that GPOs are not providing any benefit for. We were brought
into the Diagnostics approach by a number of our large IDNs who said,
‘we’re getting killed with the data.’ Amerinet alone has 1,200
contracts. Goodness knows how many million line items of product. Those
products are constantly changing, the prices are changing…I don’t really
know how hospitals even keep up with the amount of data they’ve got to
deal with. Again, they turn to their GPO and say, ‘you’ve got to help us
with this.’ Or they turn to the vendors because certainly the vendors
are providing a lot of these solutions as well. That’s the kind of thing
that brought us into the Diagnostix business. It’s still in its start-up
stage. We’ve had a couple of pilot projects. We’ve really shown some
great results. It’s worth the investment on Amerinet’s part to support
its members this way.
What kind of investment did it
involve?
It’s all internal development expense. It’s not small, I
can tell you that. I can’t get into numbers, but it’s not an
insignificant investment because it’s very software- and data
processing-oriented.
Can you tell me if it’s in the six-
or seven-figure range at least?
It’ll be well into seven figures.
Does this get into contract price
accuracy and data file maintenance?
Yes. It’s price file maintenance, price accuracy
management, local and national contract maximization, non-contract
product analysis.
Will this be available to everyone
and not just Amerinet members?
We’re going to proceed slowly on this. We exist for the
benefit of our members and right now we’re limiting it to our existing
members. But that’s not to say that at some point in time that it might
stand on its own. Right now it’s being done as a traditional support to
our existing members.
GPOs and HIGPA this year announced
their support of the GLN, but they’ve also supported the UPN and other
standards. To truly enjoy the benefits of a standard why doesn’t it make
sense to endorse and implement only one?
Make sure that you’re not confusing different things
here. The UPN is different than GLN. Very different. The UPN is a
uniform product number. That’s trying to get all the stakeholders in the
business to try to use a standardized format for how you number and
identify a product. I think you know what a mess that is. Manufacturers
have a number, and then each distributor takes that number and modifies
it, and when it goes to the hospital a lot of times the hospital assigns
its own unique number to it. Clearly the UPN is an initiative that
everybody recognizes that we need to do. It’s just very difficult to get
all the different elements of the supply chain to agree to adopt it at
the same time and in the same way.
The GLN is a little bit different. That’s the identifier
system for all of the different players in the supply chain – the
hospitals and different delivery sites of the hospitals, the nonacute
care facilities, the suppliers, even the GPOs. Having a standardized
identifier system so that when you talk about a particular facility that
is a purchaser or receiver of goods and services that everybody
understands that there’s a single identifier for that entity. That’s
what the GLN is all about.
So they’re complementary to one
another. One identifies a facility; the other identifies a product.
Absolutely right. A perfect example: When we send a list
of our members – people that are eligible to be on a contract – to our
suppliers, wouldn’t it be wonderful if all we had to do is give them the
GLN for those members? If it was already loaded in the supplier’s system
so that there would never be any question of who was eligible to get a
contract or not? Then the reporting would come back the same way. It
would take so much of the rework and the inefficiency out of the system.
CHeS has done a lot of heavy lifting on this and we’re one of the core
members of CHeS. We certainly support that initiative.
How much does the federal
government’s recent actions against the group purchasing industry impact
how it operates?
Obviously, there’s been discussion about the potential
need for additional laws. My feeling is that continued enforcement of
the existing laws and regulations is really the appropriate thing to do.
I just don’t believe that there is a systemic problem within the group
purchasing industry. I think if you asked most provider organizations –
most hospitals and systems – and even if you asked the majority of the
healthcare supplier community, all would agree with that statement.
Ultimately, what do you think the
federal government (e.g., Senate Judiciary subcommittee on antitrust,
DOJ, FTC) is trying to accomplish? Aside from eliminating the safe
harbor for GPOs, what can it reasonably do?
I’ve had a lot of dialogue directly with the antitrust
subcommittee folks that have been involved with this. I truly believe
that they are interested in the same thing we are. Their primary
objective here is to make sure that there is an open and competitive
marketplace for medical products and devices, which is exactly the way
we feel and the way most GPOs that I know feel. GPOs thrive on
competitive environments. Uncompetitive environments stifle what we try
to do. I don’t think there’s any motivation beyond that. I’m optimistic
that continued dialogue with the Senate subcommittee and the views and
opinions from all the different parts of the supply chain will help us
come to an agreement in this issue. I believe everyone involved wants to
ensure that there is an open, competitive, level playing field so that
all appropriate medical products and devices that need to be in the
system are available, and that members have the ability to use the
products that meet their needs the best from either a clinical or
economic perspective. And it’s all done in a proper and ethical way. I
don’t think there’s anything more to it than that.
Do you think the safe harbor is
safe?
In terms of the exemption on the administrative fees? I
don’t believe the Safe Harbor protection for administrative fees is in
jeopardy now. I think if administrative fees were being used as a shield
to cover inappropriate behavior then that’s a different story. But I
really don’t get that sense from the subcommittee.
The Senate subcommittee’s bill
addressed administrative fees in particular. What’s to prevent GPOs from
complying with the letter of the bill but breaking the spirit of the
bill and reclassifying some portion of the administrative fees they
collect as something else?
That would be a risky strategy for someone to do. The
important thing to understand is the guidelines in the safe harbor
suggest that fees of 3 percent or less are reasonable for the services a
GPO renders to their members and their suppliers. I can’t speak for
other GPOs but if you take a look at the overall average administrative
fee I can assure you that for Amerinet it’s significantly less than 3
percent. If there is a contract at a little more than 3 percent there
are dozens of contracts that are well below 3 percent. The overall cost,
if you want to identify it as such, for those services is far less than
just taking the $65 billion times 3 percent. It’s not anywhere near
that.
One of the key arguments posited
against GPOs is their use of sole-source agreements. Doesn’t "banning"
them defeat the fundamental purpose of GPOs’ volume-buying philosophy
and if the feds can do that in healthcare can they also do it in the
retail market against the likes of Costco and Wal-Mart? Why?
Amerinet’s long-standing philosophy has been to provide
its members with choices of suppliers. So the sole-sourcing contract
issue is not nearly as much for us as it is for some other
organizations. It doesn’t directly impact us. But on the other hand
there are times when market dynamics either dictate that a sole-source
agreement is the only thing that’s available or perhaps the value from
that is so compelling to the member that to do otherwise would be
irresponsible, then that’s another decision that has to be made. It’s
important to understand that sole-source contracting is a widely
accepted business practice of nearly all industries, including the
federal government. It’s not illegal. It’s not even unethical. It’s
considered good business. The greater question, which has been raised,
is not necessarily sole-source contracts per se, but to ensure that
participation on sole-source contracts by the members is done on a
voluntary basis without penalty. The members need to be the ones to
decide if they want to participate in a sole-source agreement and that
they understand what the implications are and that it doesn’t compromise
any of their other needs. They should be free to do that. That’s the way
we operate. We don’t have a lot of sole-source contracts. We do have
some. But I’m not aware of any supplier concerns or complaints about the
way we’ve done it when we’ve done it in the past.
Despite the debate over discounts
and rebates, how does a GPO like Amerinet genuinely prove to its
existing and prospective members that it can save healthcare facilities
money?
We don’t own our members’ facilities. Nor do they own
us. So they don’t have any financial interest in our success or failure.
As a result, we have to earn our business every single day on every
contract for every member. Our members are threatened with economic
survival. They ensure that they’re getting the best deal they can on
every product before they use our contracts. They put our contracts to
the test every single day. Last year, our contract purchases increased
by a little over 7 percent. We estimate the savings to our members was
in excess of $300 million. We shared an additional $30 million in cash
back to our members. And we added 4,000 new members. Those things
suggest that if we weren’t delivering legitimate cost-reduction value to
the members those numbers wouldn’t be where they are.
Although trendy at the turn of the
millennium among many businesses (particularly in the dot-com world),
Amerinet decided to lower-case the "N" in its name. What was the
reasoning behind it and how much did it bug you?
Well, as you know, Rick, for a long time this was a
personal struggle for me. I’ve been part of Amerinet from the very first
days of its conception. To me the Capital N was part of what
differentiated Amerinet from all the other ‘Little N’ companies. But
being part of an ever-evolving dynamic organization that’s been known
for innovation and leadership, when the marketing folks told me that the
‘Big N’ had to go I just had to accept their wisdom and move on. We had
a suitable ceremony to retire the Big N, and I’m proud to say that it
now hangs on a plaque that was presented to me by the Amerinet employees
in a prominent place in our office. And I want to thank you for being so
sensitive to my feelings.
What was more difficult was that for 18 years whenever
anybody dropped the Capital N I was all over them. [Laughter] At our
Annual Supplier Update in October 2003 I had to stand up there in front
of the room and drop the banner on the new logo with the small N and I
had some humble pie to eat!
Now do you carry the big N to all
the board meetings you chair?
[Laughter] No, it has a fixed residence here on my wall.
I can send you a picture of it if you want?
HPN